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a b s t r a c t
INTRODUCTION: Squamous-cell carcinoma (SCC) of themiddle rectum is a rare disease with an estimated
incidence of 0.1–0.25/1000 colorectal neoplasms. Literature is represented essentially by case report and
short series, and only seventy-six cases of colorectal squamous carcinoma have been documented in
literature.
PRESENTATION OF CASE: We report the case of a SCC of the middle rectum, associated to an ureteral
invertedpapilloma, occurred inapatientwithapasthistoryofprostate cancer treatedwithprostatectomy
and radiotherapy.
DISCUSSION: Colorectal squamous-cell carcinoma is a rare disease. This localization is more frequent
than the right colon, but no more epidemiological informations are actually available apart from a slight
predominance of the female sex. Risk factors for SCC of the rectum are unknown and many hypotheses
have been evocated. Because of its rarity, the interpretation of available information is clouded by a lack
of uniformity in diagnosis and treatment.
CONCLUSION: Treatment of SCC remains very challenging, and the acquisition of more consistent data is
needed.
© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
Squamous cell carcinoma (SCC) of the middle rectum is a rare
disease with an estimated incidence of 0.1–0.25/1000 colorectal
neoplasms. Literature is represented essentially by case report and
short series. Since Schmidtmann in 1919 reported the first case
SCC of the colon,1 76 cases of colorectal squamous carcinoma have
been documented. Risk factors for SCC of the rectum are unknown
and many hypotheses have been evocated. Because of its rarity,
the interpretation of available information is clouded by a lack of
uniformity in diagnosis and treatement.2
We present a case of SCC of the middle rectum, associated to
an ureteral inverted papilloma, occurred in a patient with a past
history of prostate cancer treated with prostatectomy and radio-
therapy.
2. Presentation of case
A 73-year-old man consulted to emergencies for peri-anal pain.
He was complaining for pelvic discomfort and constipation associ-
ated to rectal bleeding fromabout 8months.Hehada familyhistory
of colonicmalignancy andapast history of prostate cancer (pT3N1),
treated with prostatectomy, hormonal therapy and radiotherapy
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seven years before. Physical examination was normal, while rectal
exploration demonstrates a mass involving half circumference of
the middle rectum on the posterior and left aspect of the pelvis.
Blood samples showed a moderate anemia with hemoglobin at
11.2 g/dl. Colonscopy revealed a large lesion of the middle rectum,
at 7 cm from the anus (Fig. 1); the underlying mucosa, as well as
the anus were normal. Biopsies demonstrate a squamous cell car-
cinoma. Trans rectal ultrasound revealed a contact of the tumor
with the left aspect of the pelvis and enlarged lymph nodes. The CT
scan confirmed the local extension, demonstrating the absence of
distant or nodal metastasis, while a solid lesion of the right ureter
close to the right iliac cross, suggestive for urotelial neoplasm was
incidentally founded (Fig. 2).
After multidisciplinary discussion neoadjuvant treatment was
excluded because of the previous radiotherapy for prostate cancer.
The patient was addressed to surgical treatment. A lower ante-
rior resection with total mesorectal excision combined to the right
ureteral resection was performed. Histology confirmed an atypi-
cal squamous cell rectal cancer, that was classificated pT3N1, and
an inverted papilloma of the right ureter (Fig. 3). Post-operative
outcome was uneventful. Patient died 4 months later for local
recurrence and distant dissemination (nodal and pulmonary).
3. Discussion
Colorectal squamous cell carcinoma is a rare disease. The first
case of SCC of the rectum was described by Raiford in 1933.1 This
http://dx.doi.org/10.1016/j.ijscr.2014.10.097
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Fig. 1. Vegetating and partly ulcerated lesion ofmiddle rectum. The cancer has spread to several centimeters into the rectum, occupyingmore than half of the circumference.
Fig. 2. (A) CT scan showing solid lesion of the right ureter close to the right iliac cross, suggestive for urotelial neoplasm. (B) CT scan showing the presence of middle rectum
lesion, involving more than half of the circumference. Evidence of possible involvement of the lymph nodes of mesorectum.
localization is more frequent than the right colon, but nomore epi-
demiological informations are actually available apart from a slight
predominance of the female sex.1,2
The aetiopathogenicity of SCC is unknown, but several causes
have been evocated. It is general opinion that the radiation
exposure might play a role in inducing metaplasia and cancer
degeneration. In the present report radiotherapy could be evocated
because of the radiant exposure for the treatment of prostate can-
cer seven years before. Moreover, the presence of a synchronous
pelvic tumor in the same irradiated field (inverted papilloma of
Fig. 3. Squamous epithelial cells in the context of glandular mucosa infiltrating the submucosa. The simple tubular glands show superficial hyperkeratinization. Evidence of
extensive infiltration of lympho-monocytic cells in the submucosa (hematoxylin–eosin ×20).
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the right ureter), allow us to support this hypothesis. However
othermechanismsof inflammation (inflammatoryboweldiseaseor
infections) could be equally involved.2 Another mechanisms evo-
cated is the possible differentiation from pluripotent stem cells or
the squamousdifferentiation fromadenomaandadenocarcinoma.3
As well, Michelassi suggested that epithelial damage may induce
proliferation of uncommitted basal cells into squamous cells, with
subsequentmalignant transformation.4 Finallywehave tomention
that some histological reviews of adenocarcinomas have demon-
strated areas of squamous differentiation, suggesting that SCCmay
arise frompreexisting adenomasor adenocarcinomas.5,6 Neverthe-
less, a critical analysis of risk factors for SCC is still impossible.
The clinical presentation of SCC is similar to that of adenocar-
cinoma of the rectum but treatment and prognosis are not so well
known. In 1979 Williams proposed four criteria to be fulfilled for a
correct diagnosis of SCC: absenceof extensionof the tumor fromthe
anal squamous epithelium; absence of evidence of squamous cell
carcinoma of any other primary site; absence of squamous-lined
fistula tract to the affected bowel; confirmation of SCC by histolog-
ical examination (without glandular differentiation).6 We found,
including our report, 76 cases described as clinical cases or little
series of colorectal squamous carcinoma, that accomplished these
criteria.
As well as for rectal adenocarcinoma, diagnosis is made by
endoscopy with biopsies. Some considerations have to be made
regarding the histology, because of the importance of differenti-
ating this form of cancer from other rectal tumors. As suggested
by Nahas immunohistochemistry helps to differentiate rectal from
anal tumor, notably the cytocheratins CAM 5.2 is able to stains
rectal SCC but not anal SCC.7 Pre-operative staging includes
trans-rectal ultrasound, MRI and CT scan. As well as for rectal ade-
nocarcinoma, trans-rectal ultrasound and MRI should be preferred
for T and N staging.
As showed in two recent reviews of the literature, treatment is
far to be assessed.1,2 Many treatment have been proposed depend-
ing by tumor location, TNM stage, age of the patient and presence
of comorbidities (chemotherapy or radiotherapy alone or in combi-
nation, local excision or surgical excision alone or in combination
with chemo-ratiotherapy).8 Most authors believe that surgery is
the gold standard, however, following the axiom with rectal ade-
nocarcinoma and considering the efficacy of chemoradiotherapy
alone for SCC of the anus,9 it seems reasonable to regardwith atten-
tion topre-operativeneoadjuvant radio-chemotherapy. This iswell
represented in two different pubblications10,11 about SCC of the
rectum. Surgery alone could be reserved for patients who cannot
undergo neoadjuvant treatment. The issue of which chemother-
apeutic regimen to use in combination with radiotherapy, has
not been evaluated for SCC of the rectum. Nevertheless, follow-
ing the paradigm of the effectiveness in the treatment of SCC of
the anus, most appropriate drugs are mitomycin C and cisplatin
both combined with fluorouracil and radiotherapy. However, as
demonstrated by Ajani12–14 in a randomized controlled trial, there
is no difference in survival, local recurrence and distant metastasis
among the two groups for patients affected by SCC of the anus. As
consequence, the most appropriate surgical strategy appears to be
the result of the better treatment combination of rectal adenocar-
cinoma and SCC of the anus.
In conclusion, as a result of this lack of knowledge, treatment
of SCC remains very challenging, and the acquisition of more
consistent data is needed. Patients should be addressed to hospitals
at high volume of colorectal procedure, in order to assess the best
standard of care.
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